- Oliver Technow, CEO, BioVectra Inc. (Chair)
- Roberto Bellini, President & CEO, BSQUARED Capital (Vice Chair)
- Andrew Casey, President & CEO, BIOTECanada (Secretary)
- Gordon McCauley, President and CEO, adMare BioInnovations (Past Chair)
- Paul Petrelli, Vice-President & General Manager, Gilead Sciences Canada Inc.
- Tamer Mohamed, Founder & CEO, Aspect Biosystems
- Karen Heim, Vice President and General Manager, Canada, Alexion Pharmaceuticals
- Anne Woods, Managing Director, Life Sciences, Banking, RBCx
- Norma Biln, CEO, Augurex
- Colleen Coxson, Country Manager, Alnylam Pharmaceuticals
- Andrew Haigh, President and CEO, Adapsyn Bioscience
- Brigitte Nolet, President & CEO, Roche Canada Pharma
- Nancy Pei, Partner, Smart & Biggar
- Sanj Singh, President & CEO, Temple Therapeutics B.V.
- Jamie Stiff, Managing Director, Genesys Capital
- Ali Tehrani, Partner, Amplitude Ventures